This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rodríguez-Avial, I.
Right arrow Articles by Picazo, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodríguez-Avial, I.
Right arrow Articles by Picazo, J. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Antibiotics

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, February 2005, p. 820-823, Vol. 49, No. 2
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.2.820-823.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

In Vitro Activity of Telithromycin against Viridans Group Streptococci and Streptococcus bovis Isolated from Blood: Antimicrobial Susceptibility Patterns in Different Groups of Species

Iciar Rodríguez-Avial,* Carmen Rodríguez-Avial, Esther Culebras, and Juan J. Picazo

Servicio de Microbiología, Hospital Clínico San Carlos, Madrid, Spain

Received 12 August 2004/ Returned for modification 7 September 2004/ Accepted 4 October 2004

The in vitro activities of penicillin, erythromycin, clindamycin, and telithromycin were determined against 155 viridans group streptococci (VGS) and 18 Streptococcus bovis blood isolates. Heterogeneity in the susceptibility patterns and macrolide resistance phenotypes and genotypes in the different groups of VGS was detected. We found seven telithromycin-resistant S. bovis isolates all harboring the erm(B) gene.


* Corresponding author. Mailing address: Servicio de Microbiología Clínica, Hospital Clínico San Carlos, Plaza de Cristo Rey s/n, 28040 Madrid, Spain. Phone: 34 91-3303486. Fax: 34 91-3303478. E-mail: iciaravial{at}hotmail.com.


Antimicrobial Agents and Chemotherapy, February 2005, p. 820-823, Vol. 49, No. 2
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.2.820-823.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • DiPersio, L. P., DiPersio, J. R., Frey, K. C., Beach, J. A. (2008). Prevalence of the erm(T) Gene in Clinical Isolates of Erythromycin-Resistant Group D Streptococcus and Enterococcus. Antimicrob. Agents Chemother. 52: 1567-1569 [Abstract] [Full Text]  
  • Ergin, A., Ercis, S., Hascelik, G. (2006). Macrolide resistance mechanisms and in vitro susceptibility patterns of viridans group streptococci isolated from blood cultures. J Antimicrob Chemother 57: 139-141 [Abstract] [Full Text]